Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Providing Positive Outcomes through Compounding for Animal Cancer Patients

Author(s):  Davidson Gigi S

Issue:  Jul/Aug 2000 - Compounding for Hospice and Cancer Patients
View All Articles in Issue

Page(s):  264-272

Download in electronic PDF format for $65

Abstract:  The role of the compounding pharmacist is critical during the treatment of animals with cancer. In this article, the author discusses methods of therapy, considerations for extrapolation of therapies, chemoresponsive tumors (lymphoma, mast cell tumor, osteosarcoma, bladder cancer, postvaccinal sarcomas, equine tumors, sarcoids, squamous cell carcinoma and melanoma), specific intralesional and topical chemotherapy and immunotherapy, adverse sequelae to cancer treatment in animal patients, therapeutic options for pain in the cancer patient and frontiers of veterinary cancer therapy. She also provides tables with the following information: a chart showing conversion of body weight in kilograms to body surface area in meters squared for dogs, a chart showing conversion of body weight in kilograms to body surface area in meters squared for cats, compounded cancer treatment options for oral administration, considerations for extrapolation of human therapies to animal patients, a treatment protocol for canine lymphoma, a feline lymphoma treatment protocol, canine mast cell tumor treatment options, a canine osteosarcoma treatment protocol, a feline vaccine-associated sarcoma treatment protocol, equine sarcoid treatment options, equine squamous cell carcinoma treatment options, equine melanoma treatment options, compounded intralesional and topical chemotherapeutic agents, treatment options for adverse sequelae to cancer treatment and therapeutic options for pain management in the veterinary cancer patient.

Related Keywords: animal patients, animals, antineoplastic, bladder cancer, cancer, cat, chemotherapy, cytotoxic, dog, equine tumors, horse, immunotherapy, lyphoma, mast cell tumor, melanoma, oncolgists, osteosarcoma, pets, postvaccinal sarcomas, sarcoids, squamous cell carcinoma, veterinary


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Providing Positive Outcomes through Compounding for Animal Cancer Patients
Davidson Gigi S
Jul/Aug 2000
Pg. 264-272

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George
, Daleo Charles, Batson SL
Sep/Oct 2019
Pg. 358-364

Compounding for Cancer in Companion Animals
Mixon William
, Northrup Nicole, Vail Jane
Jan/Feb 2009
Pg. 42-49

Compounding Antiangiogenic Cancer Therapy for Animals
Davidson Gigi S
May/Jun 2005
Pg. 195-198

Basics of Compounding for the Treatment of Warts
Allen Loyd V Jr
Mar/Apr 2004
Pg. 126-129

Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease
Patterson Donna
, Ford Peter R, Gallon Marlene D
Jul/Aug 1997
Pg. 242-243

Drugs Banned for Use in Food Animals: An Explanation
Davidson Gigi S
Mar/Apr 2001
Pg. 101-103

The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
Mar/Apr 2001
Pg. 86-88

Compounding Prokinetic Medications for Companion Animals
Gaskins Jessica
Jul/Aug 2012
Pg. 276-286

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions